JAMIE LAMM: Open Payments
NPI 1770774028 · EAU CLAIRE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 33 payments from 14 companies in 2025. Trend: 2023 $472 · 2024 $477 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $164 |
| Sage Therapeutics, LLC | 6 | $120 |
| Pacira Pharmaceuticals Incorporated | 1 | $98 |
| Novo Nordisk Inc | 4 | $76 |
| Astellas Pharma US Inc | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Pharmacosmos Therapeutics Inc. | 1 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Organon LLC | 1 | $27 |
Products named: ZURZUVAE, Exparel, LILETTA, Veozah, MYFEMBREE, MONOFERRIC, Qelbree, Wegovy.
Industry payments across WI — which companies pay providers there.
